Publication | Open Access

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

VaccinationVaccine SafetyCross-protectionVaccinologyMicroneedle PatchImmunologyTiv-mnp 2015Vaccine TestingVaccine EfficacyInactivated Influenza VaccineInfluenza VaccineInfection ControlMedicineInfluenza Vaccines